+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 22 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are evaluating the safety and effectiveness of several investigational long-acting antibody treatments, both alone and in combination, for adults with moderately to severely active ulcerative colitis UC. This Phase 2 platform study involves multiple centers and aims to improve treatment options for this condition by comparing different therapies. The study consists of two parts. Part A was an open-label phase assessing safety and early effectiveness of three monotherapies, which completed enrollment in April 2026. Part B is currently enrolling and is a randomized, placebo-controlled phase testing three monotherapies and three combination therapies against placebo. Participants will receive intravenous induction and subcutaneous maintenance treatments, with different dosing regimens evaluated over time. Participants will be monitored through regular assessments including endoscopy and histology to measure disease activity and response. The main outcomes include clinical remission and histologic improvement after 12 weeks, with longer-term remission assessed up to 48 weeks. Safety and efficacy data will be collected throughout, with treatment duration and follow-up determined by study protocol. The total study completion is expected by March 2028.

Age: 18Years - 75YearsAll GendersPhase 2
276 locations
E

Actively Recruiting

Healthy Volunteer

This research investigates the ability of Omnichroma composite restorations to match the color of tooth structure after in-office dental bleaching. It addresses the challenge that composite restorations do not lighten with bleaching like natural teeth, which can lead to replacing restorations and potentially weakening teeth. The study tests whether single-shade resin-based composites perform similarly to conventional multi-shade composites in color matching and patient and dentist satisfaction. Participants will receive in-office bleaching treatment using hydrogen peroxide 40% with either conventional multi-shade nanohybrid composite restorations or single-shade Omnichroma composite restorations. The study is randomized with two groups comparing these materials across anterior teeth. Color measurements will be taken before and after bleaching, and satisfaction will be assessed by blinded dentists and patients. During the study, patients will have their teeth and restorations evaluated with a digital spectrophotometer and subjective assessments of color match. Follow-up visits include patient satisfaction surveys two weeks post-bleaching and color measurements over one year. Dentists will also evaluate color blending. The study involves monitoring for color match and satisfaction outcomes to assess the performance of the composites after bleaching.

Age: 18Years +All GendersPhase Not Applicable
1 location
E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating how well single-shade resin-based composites RBCs match the color of natural teeth compared to conventional multi-shade composites in anterior tooth restorations. This study focuses on the aesthetic success of dental restorations by assessing the shade-matching ability, patient satisfaction, and dentist satisfaction with these materials. The trial includes 240 teeth from patients, studying different restoration types such as Class V, III, IV, and diastema closures. Participants will be divided into two groups one group will receive restorations using conventional multi-shade nanohybrid RBC, and the other will receive a single-shade composite with color adjustment potential. Each patient will have at least one tooth restored with each type, allowing a direct comparison. The study uses a double-blind design to keep both patients and clinicians unaware of which material is used. Satisfaction with color blending will be assessed one week after treatment. During the study, researchers will use a digital spectrophotometer to measure tooth color and evaluate patient and dentist satisfaction over one year. Follow-up assessments will include subjective feedback using a Visual Analogue Scale VAS. The trial aims to monitor the color adaptation of the composites and the overall aesthetic integration in the restored teeth. Participants will be observed for up to one year to evaluate the outcomes and satisfaction levels.

Age: 18Years +All GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are investigating the use of site-specific bone-density assessment and software-recommended drilling protocols to improve primary stability of dental implants. This study focuses on adults needing a single implant in a healed premolar or molar site and evaluates the relationship between bone density at the implant site and implant stability immediately after placement. The trial also examines agreement between different bone-density classification methods and the accuracy of implant placement. Participants receive digitally guided dental implant placement using the R2GATE Digital EYE software, which analyzes cone-beam computed tomography images to assess bone density and recommend a tailored drilling sequence for the implant site. The implant site preparation follows the softwares suggested drilling protocol, and placement is guided by a digitally planned surgical guide. Primary implant stability is measured right after implant placement using insertion torque and resonance frequency analysis. During the study, participants undergo digital implant planning with imaging and surgical procedures using the software and devices designed to measure primary stability and placement accuracy. Researchers collect data on insertion torque, implant stability quotient, and implant placement depth compared to the digital plan. The study monitors these outcomes immediately after surgery to assess the clinical applicability of the bone-density assessment and drilling protocol. The total participation duration varies based on implant placement and assessment timing.

Age: 18Years +All GendersPhase Not Applicable
1 location
S

Actively Recruiting

Healthy Volunteer

Researchers are studying the effects of topical hyaluronic acid on reducing pain and improving bone healing after the surgical removal of lower wisdom teeth. This clinical trial uses a split-mouth design, meaning each patient receives both treatments for comparison. The study will enroll 20 patients aged 18 to 35 years with specific types of impacted wisdom teeth, aiming to assess how hyaluronic acid combined with a collagen sponge affects recovery compared to collagen sponge alone. Each participant will undergo surgical extraction of both lower wisdom teeth performed by the same experienced surgeon. One extraction site will randomly receive hyaluronic acid gel with a collagen sponge, while the other site will receive only a collagen sponge. The procedure includes local anesthesia, bone removal if needed, and suturing, followed by standard postoperative care and suture removal after seven days. Pain will be recorded at 12 hours, day 3, and day 7 after surgery. Bone healing will be assessed through X-rays and tissue samples taken weeks after extraction. Participants will have their pain levels recorded using a visual scale and undergo radiographic imaging about eight weeks post-surgery to evaluate bone healing. Histological analysis of bone samples from both sockets will be done six weeks after the procedure to measure new bone formation. The study will analyze differences in pain and bone healing between the treated and control sites. The total study period includes surgery, follow-up visits, imaging, and tissue biopsy for detailed evaluation of healing.

Age: 18Years - 35YearsAll GendersPhase Not Applicable
1 location
E

Actively Recruiting

This research evaluates a digital e-clinic designed to support mental health, psychosocial, and reproductive health for women and adolescent girls in Jordan, including both Jordanian and Syrian refugee participants. The study focuses on how this integrated e-clinic can help improve mental health, well-being, reproductive knowledge, attitudes, and access to care. It aims to assess the acceptability, feasibility, and cultural fit of the e-clinic as a health service. Participants receive access to a culturally tailored digital platform offering individualized psychosocial support, scheduled interactions with trained healthcare providers, educational content, self-help resources, and referrals to additional services when needed. The intervention is delivered remotely, allowing participants to use the e-clinic from their own location without routine in-person visits. Safety and referral procedures are in place for urgent or specialized needs. Participants complete baseline assessments before starting the e-clinic use and follow-up assessments about three months later or after finishing the intervention. Researchers measure changes in depressive and anxiety symptoms, psychological well-being, post-traumatic stress symptoms, electronic health literacy, reproductive health knowledge and attitudes, and participant satisfaction. Use of psychosocial sessions, educational modules, peer support, and referrals are also tracked, alongside privacy and cultural appropriateness. The study runs from August 2026 to September 2027.

Age: 14Years - 65YearsFEMALEPhase Not Applicable
1 location
E

Actively Recruiting

This research focuses on shoulder pain that often occurs after laparoscopic gastric sleeve surgery, a common procedure for managing obesity. The study aims to compare the effects of an anesthetic plan that includes ketamine to one that does not, in order to see how they influence the incidence and severity of shoulder pain following surgery. Shoulder pain after laparoscopy is a frequent and sometimes long-lasting issue, thought to be caused by irritation of the diaphragm and nerves during the procedure. Participants will be assigned to one of two groups one will receive an intraoperative intravenous ketamine infusion at a dose of 0.3 mg per kilogram per hour as part of their anesthetic management, while the other group will not receive ketamine. The study compares these two approaches to see if ketamine reduces shoulder pain after surgery. The trial is randomized and uses quadruple masking to ensure unbiased results. During the study, participants will be monitored for pain levels using the Visual Analog Scale VAS and the COMFORT scale over a period of six months. Researchers will also observe recovery duration, hospital stay length, post-operative pain medication needs, side effects from ketamine, and nausea or vomiting after surgery. The total follow-up period extends to six months to assess these outcomes thoroughly.

Age: 18Years - 60YearsAll GendersEarly Phase 1
1 location
E

Actively Recruiting

Researchers are studying adults aged 18 and older who live with obesity and have a liver disease known as non-alcoholic steatohepatitis NASH or metabolic associated steatohepatitis MASH with moderate or advanced liver fibrosis. The study aims to evaluate whether a medicine called survodutide can improve liver function in people with these conditions. It is a Phase III, randomized, double-blind, placebo-controlled trial conducted at multiple centers. Participants are randomly assigned to one of two groups one receives weekly injections of survodutide, and the other receives placebo injections that look the same but contain no medicine. The survodutide dose is gradually increased until reaching the target dose. All participants receive counseling on diet and exercise. The study includes two parts the first focuses on the effect of survodutide on NASH and fibrosis over one year, and the second assesses its long-term safety and effectiveness over up to seven years. Participants stay in the study for up to seven years, attending regular visits either in person or remotely via video call. Visits occur every two weeks initially, then every four to six weeks, and later every three months. Doctors monitor health, record any side effects, and measure body weight and digestive symptoms. Liver assessments include imaging and biopsies at selected visits. Participants also complete questionnaires about symptoms and quality of life. Researchers compare results between the groups to assess the medicines effects on liver health and related outcomes.

Age: 18Years +All GendersPhase 3
532 locations
O

Actively Recruiting

Researchers are investigating the long-term safety and tolerability of inclisiran in participants with heterozygous or homozygous familial hypercholesterolemia HeFH or HoFH who have previously completed specific pediatric ORION studies. This open-label, single arm, multicenter extension study aims to provide continued access to inclisiran treatment while monitoring its effects over an extended period. Participants who completed the ORION-16 or ORION-13 studies receive a fixed dose of inclisiran sodium 300 mg in solution form. Those who completed ORION-19 or ORION-20 receive inclisiran doses adjusted based on their body weight. The study involves ongoing administration of inclisiran to assess long-term treatment outcomes. During the study, participants are monitored for adverse events and serious adverse events from the first day up to approximately 1080 days. Researchers measure changes in LDL cholesterol levels compared to baseline from the previous studies. Participants will have regular visits and assessments to track safety, tolerability, and lipid changes throughout the study duration, which may last up to nearly three years.

Age: 2Years - 100YearsAll GendersPhase 3
52 locations
L

Actively Recruiting

Researchers are studying the safety, effectiveness, and how the body processes Vibegron in children aged 2 to less than 18 years who have neurogenic detrusor overactivity NDO and regularly use clean intermittent catheterization CIC. This open-label trial aims to better understand Vibegrons impact on this pediatric population over a long-term period. Participants receive Vibegron orally once daily, with doses adjusted based on their weight. The study has two parts Part A where doses may be reduced up to two times based on individual responses and safety, and Part B where participants receive a dose selected by a safety monitoring board based on data from Part A. Participants are grouped into cohorts according to weight ranges. Throughout the study, participants undergo assessments including bladder function tests and questionnaires measuring incontinence and symptom severity. Researchers monitor changes in bladder capacity, detrusor activity, catheterized volumes, leakage episodes, and quality of life over approximately 52 weeks. Safety and drug processing are continuously evaluated, with the study expected to complete around September 2030.

Age: 2Years - 17YearsAll GendersPhase 2Phase 3
38 locations

1-10 of 22

1